BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27711114)

  • 1. Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function.
    Figueroa-Bonaparte S; Segovia S; Llauger J; Belmonte I; Pedrosa I; Alejaldre A; Mayos M; Suárez-Cuartín G; Gallardo E; Illa I; Díaz-Manera J;
    PLoS One; 2016; 11(10):e0163493. PubMed ID: 27711114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
    Nuñez-Peralta C; Alonso-Pérez J; Llauger J; Segovia S; Montesinos P; Belmonte I; Pedrosa I; Montiel E; Alonso-Jiménez A; Sánchez-González J; Martínez-Noguera A; Illa I; Díaz-Manera J
    J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):1032-1046. PubMed ID: 32129012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up of enzyme replacement therapy.
    Lollert A; Stihl C; Hötker AM; Mengel E; König J; Laudemann K; Gökce S; Düber C; Staatz G
    PLoS One; 2018; 13(1):e0190784. PubMed ID: 29315315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns.
    Carlier RY; Laforet P; Wary C; Mompoint D; Laloui K; Pellegrini N; Annane D; Carlier PG; Orlikowski D
    Neuromuscul Disord; 2011 Nov; 21(11):791-9. PubMed ID: 21803581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.
    Gaeta M; Barca E; Ruggeri P; Minutoli F; Rodolico C; Mazziotti S; Milardi D; Musumeci O; Toscano A
    Mol Genet Metab; 2013 Nov; 110(3):290-6. PubMed ID: 23916420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term benefit of enzyme replacement therapy in Pompe disease: A 5-year prospective study.
    Kuperus E; Kruijshaar ME; Wens SCA; de Vries JM; Favejee MM; van der Meijden JC; Rizopoulos D; Brusse E; van Doorn PA; van der Ploeg AT; van der Beek NAME
    Neurology; 2017 Dec; 89(23):2365-2373. PubMed ID: 29117951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body magnetic resonance imaging in late-onset Pompe disease: Clinical utility and correlation with functional measures.
    Khan AA; Boggs T; Bowling M; Austin S; Stefanescu M; Case L; Kishnani PS
    J Inherit Metab Dis; 2020 May; 43(3):549-557. PubMed ID: 31710733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease.
    Horvath JJ; Austin SL; Case LE; Greene KB; Jones HN; Soher BJ; Kishnani PS; Bashir MR
    Muscle Nerve; 2015 May; 51(5):722-30. PubMed ID: 25155446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trunk muscle involvement in late-onset Pompe disease: study of thirty patients.
    Alejaldre A; Díaz-Manera J; Ravaglia S; Tibaldi EC; D'Amore F; Morís G; Muelas N; Vílchez JJ; García-Medina A; Usón M; Martínez García FA; Illa I; Pichiecchio A
    Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S148-54. PubMed ID: 22980766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study.
    Figueroa-Bonaparte S; Llauger J; Segovia S; Belmonte I; Pedrosa I; Montiel E; Montesinos P; Sánchez-González J; Alonso-Jiménez A; Gallardo E; Illa I; ; Díaz-Manera J
    Sci Rep; 2018 Jul; 8(1):10898. PubMed ID: 30022036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of enzyme replacement therapy on isokinetic strength for all major muscle groups in four patients with Pompe disease-a long-term follow-up.
    Andreassen CS; Schlütter JM; Vissing J; Andersen H
    Mol Genet Metab; 2014 May; 112(1):40-3. PubMed ID: 24685124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sixty six-month follow-up of muscle power and respiratory function in a case with adult-type Pompe disease treated with enzyme replacement therapy.
    Isayama R; Shiga K; Seo K; Azuma Y; Araki Y; Hamano A; Takezawa H; Kuriyama N; Takezawa N; Mizuno T; Nakagawa M
    J Clin Neuromuscul Dis; 2014 Jun; 15(4):152-6. PubMed ID: 24872213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor function and respiratory capacity in patients with late-onset pompe disease.
    Illes Z; Mike A; Trauninger A; Várdi K; Váczi M
    Muscle Nerve; 2014 Apr; 49(4):603-6. PubMed ID: 24375171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of exercise training in adults with Pompe disease: evalution of endurance, muscle strength and core stability before and after a 12 week training program.
    van den Berg LE; Favejee MM; Wens SC; Kruijshaar ME; Praet SF; Reuser AJ; Bussmann JB; van Doorn PA; van der Ploeg AT
    Orphanet J Rare Dis; 2015 Jul; 10():87. PubMed ID: 26187632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary function tests (maximum inspiratory pressure, maximum expiratory pressure, vital capacity, forced vital capacity) predict ventilator use in late-onset Pompe disease.
    Johnson EM; Roberts M; Mozaffar T; Young P; Quartel A; Berger KI
    Neuromuscul Disord; 2016 Feb; 26(2):136-45. PubMed ID: 26794303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests.
    Nuñez-Peralta C; Montesinos P; Alonso-Jiménez A; Alonso-Pérez J; Reyes-Leiva D; Sánchez-González J; Llauger-Roselló J; Segovia S; Belmonte I; Pedrosa I; Martínez-Noguera A; Matellini-Mosca B; Walter G; Díaz-Manera J
    Front Neurol; 2021; 12():634766. PubMed ID: 33796064
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term whole-body vibration training in two late-onset Pompe disease patients.
    Montagnese F; Thiele S; Wenninger S; Schoser B
    Neurol Sci; 2016 Aug; 37(8):1357-60. PubMed ID: 27193587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle magnetic resonance imaging in Pompe disease.
    Díaz-Manera J; Walter G; Straub V
    Muscle Nerve; 2021 May; 63(5):640-650. PubMed ID: 33155691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study.
    Peng SS; Hwu WL; Lee NC; Tsai FJ; Tsai WH; Chien YH
    Orphanet J Rare Dis; 2016 May; 11(1):63. PubMed ID: 27183828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation Between Respiratory Accessory Muscles and Diaphragm Pillars MRI and Pulmonary Function Test in Late-Onset Pompe Disease Patients.
    Reyes-Leiva D; Alonso-Pérez J; Mayos M; Nuñez-Peralta C; Llauger J; Belmonte I; Pedrosa-Hernández I; Segovia S; Díaz-Manera J
    Front Neurol; 2021; 12():621257. PubMed ID: 33732206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.